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Expression of mature messenger RNAs (mRNAs) requires appropriate
transcription initiation and termination, as well as pre-mRNA processing by
capping, splicing, cleavage, andpolyadenylation. A core 3′-endprocessing complex
carries out the cleavage and polyadenylation reactions, but many proteins have
been implicated in the selection of polyadenylation sites among the multiple
alternatives that eukaryotic genes typically have. In recent years, high-throughput
approaches to map both the 3′-end processing sites as well as the binding sites of
proteins that are involved in the selection of cleavage sites and in the processing
reactions have been developed. Here, we review these approaches as well as the
insights into the mechanisms of polyadenylation that emerged from genome-wide
studies of polyadenylation across a range of cell types and states. © 2013 The Authors.
WIREs RNA published by John Wiley & Sons, Ltd.
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INTRODUCTION
All eukaryotic messenger RNAs (mRNAs) as wellas many noncoding RNAs are synthesized by
the nuclear DNA-dependent RNA polymerase II (Pol
II), whose catalytic activity resides in Rpb1, the
largest of its 12 subunits. The C-terminal domain
(CTD) of Rpb1 coordinates most RNA processing
events.1 It not only recruits histone-modifying factors
and chromatin remodeling complexes to assist the
start of transcription but also, following controlled
phosphorylation and dephosphorylation of specific
serines or threonines in its heptad repeats, recruits
capping, splicing, and 3′-end processing factors at
different stages of the transcription cycle.1–3 Thus,
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the maturation of pre-mRNAs to mRNAs occurs
mostly cotranscriptionally by addition of a 7-methyl
guanosine cap to the 5′ end, removal of intronic
sequences by splicing, endonucleolytic cleavage, and
polyadenylation. The site of pre-mRNA 3′ end
cleavage is determined by the interaction of specific
sequence elements within the pre-mRNA with a
multiprotein complex whose core component is the
cleavage and polyadenylation specificity factor (CPSF)
composed of 160 (CPSF1), 100 (CPSF2), 73 (CPSF3),
and 30 (CPSF4) kDa subunits, Fip1 (FIP1L1), and
WDR33. Other members of the assembly are cleavage
factors I (CF Im), composed of 25 (CPSF5), 59
(CPSF7), and 68 (CPSF6) kDa proteins, and II
(CF IIm), composed of Pcf11 and Clp1, as well
as the cleavage stimulation factor (CstF), which
consists of 50 (CSTF1), 64 (CSTF2 and CTSF2T),
and 77 (CSTF3) kDa proteins (Figure 1; see also
recent reviews4,5). Nuclear poly(A) polymerases α
(PAPOLA), β (PAPOLB), or γ (PAPOLG) further
add a poly(A) tail of up to 250 nucleotides, the
precise length being determined by the nuclear
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FIGURE 1 | Composition of the human cleavage and
polyadenylation complex. Different colors indicate individual protein
subcomplexes. Components of the cleavage and polyadenylation
specificity factor (CPSF) complex are depicted in close proximity to the
cleavage and polyadenylation site, where CPSF1 recognizes the
polyadenylation signal AAUAAA and CPSF3 is the endonuclease
responsible for cleavage of the pre-messenger RNA (mRNA). CF Im
(cleavage factor) is depicted binding to UGUA motifs upstream of the
cleavage site, while the cleavage stimulation factor (CstF) complex
specifically interacts with a UG-rich region downstream of the cleavage
site.
poly(A)-binding protein 1 (PABPN1).6 Upon export
of the mRNA from the nucleus PABPN1 is replaced
by the cytoplasmic poly(A)-binding protein PABPC.7
Its interaction with the translation initiation factor
eIF4G at the cap complex leads to the formation of a
pseudo-circular, translation-competent mRNA.
A few exceptions to the canonical 3′-end
processing mechanism described above have been
identified. For example, although transcribed by Pol
II, replication-dependent histone mRNAs are not
polyadenylated (with a few exceptions, reported in
a recent study8). Instead, their pre-mRNAs contain
a stem-loop element downstream of the stop codon,
followed by a purine-rich histone downstream element
(HDE).9 Base pairing of the HDE with the U7 small
nuclear RNA (snRNA), which is part of the Sm class
U7 snRNP, and recognition of the stem-loop by the
stem-loop-binding protein (SLBP) lead to the assembly
of a complex containing a subset of proteins of the
canonical pre-mRNA 3′-end processing apparatus,
namely CPSF1, -2, -3, and -4 and Fip1, CstF-64 and
-77, symplekin (SYMPK),10 and CF Im.11 Cleavage
occurs at a CA dinucleotide between the stem-loop
and the HDE. Interaction between the SLBP and eIF4G
then leads to the formation of the pseudo-circular,
translation-competent form of the mRNA. Some long
noncoding RNAs such as the metastasis-associated
lung adenocarcinoma transcript 1 (MALAT1)12 and
the multiple endocrine neoplasia 1 (MEN1-/β)13
appear to be processed by yet another alternative
mechanism, ribonuclease P (RNase P).
While pre-mRNA polyadenylation takes place
in the nucleus, cytoplasmic deadenylation and read-
enylation of mature mRNAs has also been observed
(see also recent reviews14,15), initially in Xenopus
oocytes, where dormant mRNAs containing short
oligo(A) tails of 20–40 nucleotides are reactivated for
translation by addition of long poly(A) tails during
oocyte maturation. The cytoplasmic polyadenylation
element (CPE, consensus UUUUUAU) located in
the 3′ untranslated regions (UTRs) of these mRNAs
binds the CPE-binding protein (CPEB), which in turn
interacts with a poly(A) ribonuclease (PARN) and
the cytoplasmic poly(A) polymerase GLD-2. The
composition of this complex, which is modulated in
response to signals, results in either short poly(A) tails
and no translation or long poly(A) tails and protein
production.16 CPEB was also detected in postsynaptic
structures. Its phosphorylation after calcium entry into
the synapse leads to polyadenylation and subsequent
translation of CPE-containing RNAs. The resulting
proteins act as tags, marking experienced synapses and
providing a cellular basis for learning and memory.16
A multitude of factors is involved in the selection
of the 3′-end processing site among the many poly(A)
sites that a gene typically has.17,18 With the advent of
high-throughput sequencing methods, transcriptome-
wide polyadenylation sites have been determined in
a variety of conditions to reveal a very dynamic
landscape and systematic changes in poly(A) site
use that point to yet unidentified global regulators.
Four types of alternative polyadenylation (APA)
patterns are generally distinguished (Figure 2). They
either only modulate the length of the 3′ UTR or
result in distinct protein isoforms. APA at coding
region-proximal poly(A) sites has been observed in
cellular states associated with increased proliferation
184 © 2013 The Authors. WIREs RNA published by John Wiley & Sons, Ltd. Volume 5, March/Apr i l 2014
WIREs RNA Alternative polyadenylation of messenger RNA precursors
FIGURE 2 | Outline of the main alternative polyadenylation (APA)
patterns. One of the most studied patterns, tandem poly(A) sites,
corresponds to multiple poly(A) sites being located in the 3′
untranslated region (UTR) of the terminal exon. Cleavage and
polyadenylation at any of these sites will only lead to transcript
isoforms that differ in the length of the 3′ UTR, but will not affect the
protein-coding region of the messenger RNA (mRNA). Although referred
to as an APA event, cleavage and polyadenylation at a different
terminal exon is rather governed by alternative splicing decisions than
APA. APA at cryptic poly(A) sites located in introns or exons can lead to
truncated transcript isoforms with an altered coding sequence (CDS).
(e.g. cancer cells), where the short 3′ UTRs, devoid
of microRNA-binding sites, have been associated
with an increased protein output.19–21 Here, we
summarize the insights into 3′-end processing that
emerged from recent, high-throughput experimental
and computational studies. The molecular mechanism
of 3′-end processing and its regulation and relationship
with other cellular processes have been covered in a
few recent reviews.4,22–24
PRE-mRNA 3′-END PROCESSING
THROUGH THE LENS OF
HIGH-THROUGHPUT EXPERIMENTS
Approaches to the Genome-Wide Mapping
of Poly(A) Sites
The accumulation of substantial numbers of cDNA
and EST sequences in public sequence repositories
such as Genbank25 allowed the construction of
genome-wide maps of poly(A) sites.26,27 These data
then enabled inferences on global trends, such as the
preferential use of distal poly(A) sites in cells from
the nervous system compared to those from blood.28
The most recent release (version 2) of the polyA_DB
database of 3′-end processing sites contains more
than 54,000 poly(A) sites mapped to the human
genome.27 In an alternative approach, researchers
took advantage of gene expression microarrays to
estimate the signal intensities of probes mapping
to alternatively processed 3′ UTRs of mRNAs and
thereby quantify poly(A) site use under different
experimental conditions.19,20 These studies led to the
striking observation that dividing cells systematically
express mRNAs with shortened 3′ UTRs compared
to resting cells, prompting a flurry of investigations
into the underlying mechanisms. Several laboratories
then developed 3′-end sequencing protocols, which
simultaneously allow the mapping and quantification
of poly(A) site use on a genome-wide scale (see Refs
29 and 30 for a detailed comparison of the methods).
Currently, more than 4.5 billion reads, generated with
14 different protocols, can be retrieved from public
data repositories such as NCBI’s Gene Expression
Omnibus (GEO).31
The bulk of the data was contributed by
methods, such as PAS-Seq,8 PolyA-seq,17 A-seq,32 or
3′-seq,33 that rely on reverse transcription with an
oligo(dT) primer. These methods differ in the length of
the oligo(dT) primer, the way second-strand synthesis
is accomplished, and from which strand of the cDNA
molecule the sequence is read (Figure 3). PolyA-seq
and PAS-seq libraries can be generated with relative
ease but custom sequencing primers need to be used
to avoid sequencing through long oligo(T) tracts. On
the other hand, A-seq and 3′-seq sequence in the sense
direction, but to capture the beginning of the poly(A)
tail, which allows identification of the cleavage site,
they require a precise size selection of the RNA frag-
ments. The main complication with oligo(dT)-primed
libraries is that annealing of the primer at poly(A)-rich
sequences that are internal to the mRNAs can yield
false-positive 3′-end processing sites. A typical
solution is to discard putative poly(A) sites that are
followed by genome-encoded poly(A) stretches during
computational analysis. Alternatively, long oligo(dT)
primers (e.g., 45 Ts in 3′READS18) are annealed
to mRNA under stringent hybridization conditions,
thus preventing priming at shorter internal A-rich
stretches. Finally, the 3P-seq34 method has been
designed to capture specifically the poly(A) tails of
mRNAs through an initial ligation to the intact 3′
ends of polyadenylated transcripts. This protocol
identifies true poly(A) sites, but has the drawback
that it is lengthier and more complex. A direct RNA
sequencing method in which poly(A)-containing RNA
molecules are hybridized to poly(dT)-coated flow cell
surfaces where antisense strand synthesis is initiated
has also been used to map poly(A) sites.35,36 This
has the advantage that no prior reverse transcription
or cDNA amplification is needed, but on the other
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FIGURE 3 | General outline of oligo(dT)-based 3′-end sequencing
protocols (e.g., A-seq,32 PAS-seq,8 3′-seq,33 and PolyA-seq17). Poly(A)+
RNA is usually isolated with oligo(dT)-coated beads, fragmented by
alkaline hydrolysis, ribonuclease (RNase) treatment, or sonication, and
oligo(dT)-adapter primers are used to reverse transcribe the RNA.
Second-strand synthesis is accomplished with primers complementary
to 5′ adapters, random hexamer-adapter primers, or by the Eberwine
method (SMARTer kit by Clontech) where the reverse transcriptase (RT)
adds a CCC tag to the cDNA that can be primed by an adapter-GGG
molecule leading to a template switch. 5′ Adapter ligation can be
omitted when the template switch method is used or second-strand
synthesis after RT is performed with hexamer-5′ adapter primers (*).
N is any nucleotide, B is any but A, and V is any but T.
hand it requires specialized instruments that are not
widely accessible. Current estimates of the number of
poly(A) sites in the human genome, based on data of
different sequencing depths and somewhat different
computational analyses, range from 280,00017 to
1,287,130,36 with up to 58% of human genes having
multiple poly(A) sites. Given the limited accuracy of
current 3′ UTR annotations, this latter number may
be an underestimate.37
In addition to cataloging poly(A) sites, high-
throughput studies have also attempted to quantify
their relative use across tissues,17 cell lines,8,36 devel-
opmental stages,38,39 during cell differentiation,18
or following the knockdown of a specific
factor.32,33,40–42 An aspect that became apparent from
differential analysis of poly(A) site use in nuclear and
cytoplasmic RNA fractions is that promoter-proximal
poly(A) sites are preferentially used in the cytoplasmic
fraction.43 This implies that the relative stability of
mRNA isoforms affects the estimation of APA site use
and that the frequency of polyadenylation at distal
sites may be underestimated, presumably to different
extents depending on the cytoplasmic-to-nuclear RNA
ratio of specific samples.
Approaches to the Identification of Binding
Sites of RNA-Binding Proteins
Many of the factors that are involved in pre-mRNA
3′-end processing have been extensively studied and
their binding specificities are known.44–49 However,
the discovery of systematic, condition-dependent
changes in polyadenylation at the transcriptome
level points toward yet uncharacterized regulatory
interactions. A powerful method to map the sites
of interaction of RNA-binding proteins (RBPs) in
RNAs at close to nucleotide resolution consists of
cross-linking and immunoprecipitation (CLIP) of
proteins of interest followed by deep sequencing of
the protein-bound RNA fragments. Since the method
was introduced by Ule and Darnell,50,51 a number
of variants have emerged (see Figure 4 for a sketch).
To cross-link RBPs to their RNA targets UV-C light
(254 nm) is used in HITS-CLIP52 and iCLIP53 and
UV-A (365 nm), after incorporation of photoreactive
4-thiouridine into the RNAs, in PAR-CLIP.54 The
nucleotide-level resolution of the methods stems from
the propensity of the reverse transcriptase (RT) to
stop at the cross-linked nucleotide, which presumably
still carries a peptide stub that fails to be removed by
proteolytic treatment. It has been estimated that 80%
of the RT reactions generate such truncated products
that are specifically captured by RNA circularization
in iCLIP.53 When the reverse transcription does con-
tinue through the cross-linked nucleotide, frequent
skipping or misrecognition of this nucleotide leads to
cross-link diagnostic mutations that are exploited in
PAR-CLIP and HITS-CLIP. CLIP methods have been
reviewed recently55 and a comparative assessment
of their accuracy has been provided in two recent
studies.56,57 The specificity of the antibodies is a limit-
ing factor and identification of bona fide binding sites
from a large pool of unspecifically captured and ampli-
fied RNAs remains challenging, especially when the
protein has a relatively small number of binding sites.
To identify the RBP-binding sites, computational
methods that take advantage of the cross-link
diagnostic mutations in PAR-CLIP have been
proposed.54,58–61 These methods can also be applied
to HITS-CLIP, taking advantage of the mutations,
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FIGURE 4 | Schematic outline of cross-linking and
immunoprecipitation (CLIP) protocols for inferring protein interactions
sites in RNAs. Many steps are interchangeable between protocols.
Blotting after the sodium dodecyl sulfate (SDS) gel electrophoresis is
frequently used to remove contaminating RNAs that are not cross-linked
to proteins. Diagnostic mutations (substitutions, deletions, or insertions
in all protocols, T→ C mutations specifically in PAR-CLIP) are indicated.
deletions, or insertions that are introduced, albeit
with much lower frequency.56,62 It should be noted,
however, that the frequency of cross-link diagnostic
mutations in PAR-CLIP does not simply reflect
the residence time of the RBP on individual sites.
4-Thiouridine is randomly incorporated in the RNA
and its cross-linking to the RBP depends on its
occurrence in a favorable configuration in the RBP-
binding site. Thus, the frequency of cross-link
diagnostic mutations does not need to be strongly
correlated with the affinity of interaction between
the RBP and the binding site. Indeed, some evidence
suggests that a better indicator of the site’s affinity
for the protein is the enrichment of RNA fragments
originating from putative binding sites relative to the
overall transcript expression.56
Sequence Elements That Direct 3′-End
Processing
Biochemical and computational analyses of a
restricted number of genes have already yielded the
core set of sequence motifs that are recognized by
various 3′-end processing factors,63,64 and thus the
more recent transcriptome-wide analyses of poly(A)
sites did not identify strikingly novel elements.17,65
As summarized in Figure 5(a), the frequency of
adenosine nucleotides is high in the region upstream
of the cleavage site, with a peak at approximately
−21 nucleotides (nt). The peak in A’s is followed
by a U-rich stretch close to the site of cleavage,
which in human most often is between a C and
an A nucleotide. A peak of G nucleotides follows
immediately downstream of the cleavage site, followed
by a peak of U’s at approximately +25 nt. The
sequence motif most reproducibly found at poly(A)
sites is the A-rich hexamer polyadenylation signal,
which has the canonical form AAUAAA (Figure 5(b))
and has been shown to be bound by the CPSF1 3′-end
processing factor.44 Slight variations are tolerated64
and the frequency with which these polyadenylation
signals appear upstream of 3′-end processing sites
roughly corresponds to their in vitro determined
polyadenylation efficiency63 (Figure 5(b)). However,
at the level of individual genes, point mutations in
the polyadenylation signal can lead to altered relative
expression of transcript isoforms66 and ultimately to
genetic diseases.67 Although most conserved across
genes, the hexamer polyadenylation signal may also
be dispensable. This is indicated both by a study in
which CF Im was sufficient to direct sequence-specific,
AAUAAA-independent poly(A) addition in vitro68 as
well as by a recent report that an A-rich upstream
sequence combined with potent downstream signals
is sufficient to direct cleavage and polyadenylation.69
Transcriptome-Wide Mapping of Binding
Sites of Core 3′-End Processing Factors
Although application of CLIP approaches to 3′-end
processing factors32,70 largely confirmed the sequence
specificities inferred with biochemical methods, it
further revealed that the subunits of the CstF that
binds in the U/G-rich region 10–30 nt downstream of
the cleavage site exhibited the strongest positional
preference. Binding of cleavage factor I (CF Im)
occurred within the −100 to −30 nucleotide regions
upstream of the cleavage site, in a region typically
containing UGUA motifs, which are recognized by
the CF Im 25 (CPSF5) subunit of the complex
(Figure 6). Surprisingly, the CLIP data indicated that
the positioning of CF Im is similar on RNAs that
lack UGUA motifs, pointing toward yet unknown
recruitment mechanisms.32,70
Unexpectedly, CPSF and especially its largest
subunit CPSF1, which in a previous study was
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(a) (b)
FIGURE 5 | Sequence composition around poly(A) sites. Poly(A) sites were determined based on publicly available 3′-end sequencing data (NCBI
GEO entry GSE3019817), which we processed as described previously.32 (a) Position-dependent mononucleotide frequencies around the 10,000
poly(A) sites most frequently used in human cells. (b) Comparison of the frequency of occurrence of hexameric motifs at the same human poly(A) sites
and their in vitro measured efficiency in polyadenylation.63
shown to bind the conserved polyadenylation signal
AAUAAA,44 did not exhibit a strong positional
preference with respect to the cleavage site (Figure 6,
middle panel). Although some mechanistic hypotheses
were proposed,32 the reason for this discrepancy
remains to be determined.
DYNAMIC MODULATION OF POLY(A)
SITE USE
Systematic Changes in Poly(A) Site Use
in Physiological Conditions
One of the most surprising recent findings has been
the preferential use of proximal poly(A) sites in
dividing cells.19 Eighty-seven percent of the poly(A)
sites that showed a significant change in use in dividing
compared to resting cells were located proximal to
coding regions. Other cellular states associated with
increased proliferation such as malignancy show a
similar pattern of APA.21,36 Because proximal sites
are typically ‘weaker’ than distal sites,32 the simplest
models that would explain these observations are that
either (1) specific factors are recruited at the ‘weak’
sites to promote their use or (2) the core factors
have a decreased specificity in their recognition of
poly(A) sites in dividing cells. This can be caused,
for example, by an increase in the abundance of
these factors. Both of these models would require
an increased expression of the relevant proteins in
proliferating compared to resting cells. Indeed, across
the samples of the human gene expression atlas,71
the mRNA expression level of many factors that have
been implicated in the regulation of 3′ UTR length
is positively correlated with the proliferative potential
of cells (Figure 7). Surprisingly, however, the same
pattern of increased use of proximal poly(A) sites
was also observed in studies in which the expression
of individual 3′-end processing factors was reduced
by siRNA-mediated knockdown.32,33,40,72 Thus, the
molecular mechanisms underlying systematic 3′ UTR
shortening associated with proliferative states remain
to be uncovered.
The factor whose impact was studied in most
detail is the U1 snRNP, which, although necessary
for splicing in equimolar concentration to the other
snRNPs, is much more abundant within cells.
The Dreyfuss group demonstrated that the marked
knockdown of U1 snRNA leads to premature cleavage
and polyadenylation at cryptic poly(A) sites located
close (<5 kb) to the transcription start site,73 whereas
a moderate knockdown leads to various types of
transcript shortening, from alternative splicing of 3′
terminal exons located proximally to the transcription
start sites to shortened 3′ UTRs.74 Interestingly, a
study from the same group showed that 3′ UTR
shortening could be a consequence of transiently
limiting U1 snRNA levels.74 Specifically, it was found
that activation of transcription upon neural activation
leads to a spike in the ‘RNA load’ that is not matched
by a corresponding spike in U1 snRNA levels, resulting
in an effective knockdown of the U1 snRNA and
premature polyadenylation. 3′-End processing factors
may similarly become limiting in conditions associated
with increased cell proliferation. The U1 snRNP and
polyadenylation events have also been implicated
recently in the control of promoter directionality.41,75
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FIGURE 6 | Positional preferences of 3′-end processing
subcomplexes. Profiles show the densities of T→ C mutations
(PAR-CLIP32) or reverse transcriptase (RT) truncation sites (iCLIP70)
obtained in various cross-linking and immunoprecipitation (CLIP)
experiments, relative to the 1000 most abundantly used 3′-end
processing sites in the human genome.17
Although once recruited to a transcription start
site (TSS) Pol II can initiate transcription in either
direction, antisense transcripts generally terminate
within 1 kb of the TSS, probably through a
canonical termination mechanism that involves the
typical polyadenylation signal. These short antisense
transcripts are then degraded by the exosome.75
The frequency of occurrence of the poly(A) signal is
increased immediately downstream of the TSS in the
antisense direction compared to the sense direction.
Conversely, the U1 snRNP-binding motif is strongly
enriched in the sense direction, antisense morpholino-
mediated U1 snRNA knockdown causing a marked
increase in premature termination of sense transcripts
with only a small effect on antisense transcripts.41
The 25- and 68-kDa components of CF Im
(CPSF5 and CPSF6) have also been reported to
lead to shortened 3′ UTRs upon knockdown,32,40
and consistently, the depletion of Thoc5, which is
presumably involved in the recruitment of CPSF6 to
the polymerase at transcription start sites, resulted
in the same phenotype.76 In contrast to U1 snRNA,
however, knockdown of CPSF5 and CPSF6 did not
increase the use of intronic poly(A) sites. Interestingly,
the expression of CPSF5 and CPSF6 most closely
tracks the proliferative potential (Figure 7), indicating
that cells are highly sensitive to the level of these
factors and that it would be very informative to
obtain detailed measurements of the concentrations
of regulatory factors in relation to the RNA load
in various cell states. Alternatively, it may be the
post-translational modifications or the composition
of CF Im components that contribute to poly(A) site
selection. For example, phosphorylation of Ser166
in the RRM of CPSF6 modulates its RNA-binding
affinity.77 The precise composition of the CF Im
tetramer composed of CPSF5 and CPSF6 and/or
CPSF740 may be another factor that influences the
choice of poly(A) sites. Similarly, the competition
between hnRNPK and CPSF6 in binding to CPSF5
has recently been found to determine the choice of
poly(A) site in the lncRNA NEAT1.78
3′ UTR shortening can also be brought about
by the knockdown of the PABPN1 component of
the 3′-end processing machinery,33,72 which has so
far been known to control polymerization of the
poly(A) tail. The proposed model is that PABPN1
masks weak poly(A) sites that are more readily
recognized by CPSF upon depletion of PABPN1.33
Finally, cold-induced and circadian clock-regulated
RBPs Cirbp and Rbm3 also induce APA, binding
between tandem poly(A) sites to mask the proximal
and promote the use of the distal poly(A) site.79 In
this case, however, the use of distal poly(A) sites is
accompanied by an induction of cell proliferation, at
least in immature germ cells in mice.80
Coupling Between Polyadenylation
and Other Steps of Gene Expression
The effects of kinetic parameters such as the rate of Pol
II-dependent transcription on the structure of mature
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FIGURE 7 | Expression profiles of core and modulatory 3′-end processing factors in human tissues. The tissues are sorted from left to right in the
order of increasing proliferation index (defined as in Ref 40). Expression data71 were obtained from BioGPS (http://biogps.org) and processed as
described in the online Supporting Information. The numbers on the right side of each line represent the Spearman correlation coefficient between the
expression levels of the indicated gene and the proliferative potential estimated from individual samples.
RNAs are only starting to emerge. Highly transcribed
genes tend to be processed at proximal poly(A)
sites and lowly transcribed genes at distal sites.81 A
possible mechanistic model is suggested by the study of
Nagaike et al.,82 who found that strong transcriptional
activators recruit the PAF1c component of the
transcription elongation complex to the promoter,
PAF1c recruiting the 3′-end processing complex and
promoting polyadenylation at proximal sites. Such
sites are overlooked in genes whose promoters lack
strong transcriptional activation elements.82 Similar
Pol II rate-dependent effects have also been described
for splicing, where slow transcription elongation
(window of opportunity model83) is believed to allow
the assembly of spliceosomal complexes at exons with
‘weak’ splicing signals and their subsequent inclusion
in the mature mRNAs.84
It is believed that nucleosome occupancy along
the gene can modulate the Pol II elongation rate
and thereby affect poly(A) site choice. The region
immediately flanking poly(A) sites has been reported
to be depleted of nucleosomes,81,85–87 which may
be explained in part by the AT-rich sequence
that is resistant to curvature.85 However, regions
further downstream of the cleavage sites have higher
nucleosome occupancy at frequently used poly(A) sites
compared to those that are infrequently used.85,86
Differences in histone modification around these two
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(a) (b)
FIGURE 8 | Evaluation of computational poly(A) site prediction tools. (a) Prediction of poly(A) sites: the 10,000 most frequently processed 3′ ends
of human genes17 were used as the positive set and mononucleotide randomized variants of these sequences were used as the negative set to test
the ability of POLYA_SVM,88 POLYAR,89 and Dragon PolyA spotter90 (DPS). Sequences and program outputs are available online as Supporting
Information. (b) Prediction of relative use of tandem poly(A) sites in the human brain.17 We trained support vector classification models using either a
string kernel on the nucleotide sequence at positions −40 to +40 around the poly(A) site or a RBF kernel using the poly(A) hexamer score and the
G+U content in the 40 nt window downstream of the poly(A) site as input. Reported values are averaged accuracy values from a fourfold
cross-validation.
types of poly(A) sites have also been reported,86 but
it remains to be determined whether these chromatin
marks are established to guide 3′-end processing as
opposed to being triggered by the 3′-end cleavage
process itself.
PREDICTION OF POLY(A) SITES
Sequence-Based Computational Prediction
of Poly(A) Sites and Relative Poly(A) Site
Usage
Several methods that take advantage of local sequence
composition biases to predict poly(A) sites have
been proposed.88–90 By evaluating their accuracy
in predicting the 10,000 most frequently used
human poly(A) sites relative to randomized sequences
(Figure 8(a)), we found a relatively good performance,
with 6,186 of the 10,000 poly(A) sites being predicted
by all three methods. The most recently published
method, Dragon PolyA spotter,90 performs best,
identifying about 90% of the genuine poly(A) sites
at a false-positive rate of 19%. The availability of
large data sets of binding sites of RBP modulators of
3′-end processing32,70 will help to further improve
prediction accuracy. Predicting the relative use of
alternative poly(A) sites of individual genes, however,
is more challenging. On the basis of a recently
published data set of APA in the human brain,17
we evaluated the ability of standard machine learning
algorithms to predict dominant or weak use of the
proximal site (defined as at least 75% and less than
25%, respectively, of all reads mapped to poly(A)
sites associated with the gene being assigned to the
proximal site) in genes with tandem poly(A) sites
located in the same terminal exon. As input to the
algorithm we either used the nucleotide sequence
around the cleavage site (−40 to +40 nt) or the
combination of the poly(A) hexamer score (defined
as the sum over all hexamers detected in the 40 nt
window upstream of the poly(A) site of the in vitro
polyadenylation efficiency weighted by the distance of
the hexamer to the cleavage site32), and the G + U
content in the 40 nt window downstream of the
cleavage site. We found that both approaches have
limited accuracy, achieving at most 71% correctly
classified instances (Figure 8(b)). This may indicate
that poly(A) site selection not only depends on
sequence motifs located in close proximity to the
cleavage site, but that motifs that are located further
away and bind auxiliary factors with tissue- or
condition-specific expression,42,91 RNA secondary
structure,92 and chromatin marks86 also contribute
significantly to the selection process.
Understanding the functional impact of
protein–RNA interactions is challenging, because
many proteins interact with pre-mRNAs and can
modulate their processing.93 Identifying these inter-
actions with CLIP, which is applied to one protein
and one particular condition, is very time consum-
ing. An interesting alternative is now taking shape
with the availability of large collections of bind-
ing motifs of RBPs that were determined in vitro.94
These could be used in an approach that was already
developed to identify key transcription regulatory
interactions.95,96 Namely, RBP-binding sites could
be predicted with methods based on comparative
genomics, and the number and quality of RBP-binding
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sites could be related to the use of 3′-end processing
sites transcriptome-wide to identify the regulators that
have high activity in the choice of poly(A) sites in spe-
cific states or conditions. Similarly, other types of
modulation, for example, via the rate of transcription
or the density of various chromatin marks can be
included as the data become available.
CONCLUSION
The proper generation of mRNA 3′ ends requires the
recognition of sequence elements in the pre-mRNAs
by the cognate protein factors. Recently developed
high-throughput methods enabled the mapping of
both RBP–RNA interaction sites as well as of the
3′ ends that are used in specific cell types in specific
conditions. Although substantial ‘static’ information
has been gathered, it remains nontrivial to predict sites
of pre-mRNA processing and their quantitative usage
under specific conditions for a number of reasons. For
example, the recruitment of many splicing and 3′-end
processing factors occurs already at the transcription
start site, through the interaction with the Pol II
CTD, which in turn depends on post-translational
modifications of the CTD such as phosphorylation
and methylation. Furthermore, much of the RNA pro-
cessing occurs cotranscriptionally, putative poly(A)
sites emerging sequentially from the RNA polymerase.
Thus, the efficiency of processing of individual poly(A)
sites is a reflection of not only the relative affinity of
the 3′-end processing complexes for the RNA but also
of the rates at which various steps of RNA processing
proceed. Consequently, a model that satisfactorily
explains the experimental data is missing.
The fact that knockdown of the U1 snRNA
and of the core components of the 3′-end processing
machinery almost always leads to the more frequent
use of promoter proximal poly(A) sites suggests that
several safeguard mechanisms operate to prevent
premature cleavage and polyadenylation. Indeed,
premature cleavage and polyadenylation sites are
effectively and reproducibly used when the expression
of individual factors is reduced, suggesting that
safeguard mechanisms suppress the use of promoter-
proximal sites, which emerge first from the RNA
polymerase, rather than actively promote the use
of distal sites. That dividing cells, which have a
high expression of 3′-end processing factors, express
short 3′ UTRs is in apparent contradiction with the
similar phenotype caused by the siRNA-mediated
reduction in the expression of these factors. The
argument that has been made, namely that the ‘load’
of RNA to be processed changes as a function of
the cell’s state leading to an imbalance between the
number of targets and the number of processing
complexes, suggests a very promising avenue of future
research.
Systematic changes in 3′-end processing in
specific conditions such as during the cell cycle, in
proliferating compared to resting cells, and during
development have been uncovered in a variety of
studies. Although in some circumstances shorter 3′
UTRs have been associated with increased protein
output, it remains to be determined how general
this relationship is, because 3′ UTRs harbor not
only destabilizing but also stabilizing elements.
Furthermore, additional work is necessary to quantify
how large the contribution of APA to the protein
output is, relative to other regulatory mechanisms
such as condition-dependent transcription. In the
coming years, we therefore expect a very active 3′-end
processing field.
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